GAP vs GILD · P/E 9.9, rev $15.09B vs P/E 18, rev $29.44B
The Gap, Inc. (GAP) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
GAP currently screens at market cap $7.73B and trailing P/E 9.9. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the GAP and GILD stock pages for the full models.
Not investment advice.